3 recruiting, 2 not yet recruiting, 2 unknown. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Recruiting 3, Not yet recruiting 2, Unknown 2 |
Follow Intracerebral Hemorrhage: new trials by email Literature Review of Intracerebral Hemorrhage trials Research Report on Intracerebral Hemorrhage
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral Anticoagulation in Patients With Prior Deep Intracerebral Hemorrhage, Atrial Fibrillation, and Ischemic Stroke Apixaban, No Oral Anticoagulation Strategy - Intracerebral Hemorrhage, Atrial Fibrillation (AF) | Phase 4 | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 852 | 2026-10-26 | 2026-10-20 |
| Safety and Feasibility of Using Cerebrolysin in the Treatment of Primary Intracerebral Hemorrhage - a Prospective Randomized Open Blinded End-point Trial 14-day Cerebrolysin treatment, Standard of Care (SOC) - Intracerebral Hemorrhage, Hemorrhagic Stroke, Intracerebral | Phase 4 | Not yet recruiting | Cardinal Stefan Wyszynski University | 30 | 2025-10-01 | 2025-03-28 |
| International Care Bundle Evaluation in Cerebral Hemorrhage Research Reversal of Oral anticoagulation within 30 minutes, Early intensive blood pressure lowering, Treatment of pyrexia - Intracerebral Hemorrhage, Intracerebral Haemorrhage | Phase 4 | Recruiting | Region Skane | 3500 | 2025-01-07 | 2026-05-22 |
| Fufang Congrong Yizhi Capsules (FCYC) of Cognitive Impairment After Intracerebral Hemorrhage FCYC+Conventional treatment, conventional treatment - Cognitive Impairment, Intracerebral Hemorrhage | Phase 4 | Recruiting | Qinhuangdao Hospital of Traditional Chinese Medicine | 200 | 2024-11-04 | 2024-11-06 |
| The Anaesthetic Ketamine as Treatment for Patients With Severe Acute Brain Injury S-ketamine, Isotonic saline (placebo) - Subarachnoid Hemorrhage, Aneurysmal, Intracerebral Hemorrhage | Phase 4 | Recruiting | Copenhagen University Hospital, Rigshospitalet | 400 | 2023-09-15 | 2024-06-26 |
| Clinical Re-evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy ICH-1(herbal medicine with Hirudo, Tabanus), placebo, ICH-2(herbal medicine without Hirudo, Tabanus) - Intracerebral Hemorrhage | Phase 4 | Unknown | Guangzhou University of Traditional Chinese Medicine | 360 | 2013-10-01 | 2016-03-11 |
| Prevention of Venous Thromboembolism in Patients With Acute Primary Intracerebral Hemorrhage enoxaparin, enoxaparin placebo - Intracerebral Hemorrhage | Phase 4 | Unknown | University of Oulu | 320 | 2008-08-01 | 2010-07-02 |
Cerebral Hemorrhage (7) · Stroke (2) · Atrial Fibrillation (1) · Brain Injuries, Traumatic (1) · Cerebrovascular Disorders (1) · Cognitive Dysfunction (1) · Hemorrhagic Stroke (1) · Ischemic Stroke (1) · Subarachnoid Hemorrhage (1)
Brain Diseases (7) · Cardiovascular Diseases (7) · Central Nervous System Diseases (7) · Hemorrhage (7) · Intracranial Hemorrhages (7) · Nervous System Diseases (7) · Pathologic Processes (7) · Pathological Conditions, Signs and Symptoms (7) · Vascular Diseases (7) · Cerebrovascular Disorders (6) · Arrhythmias, Cardiac (1) · Brain Injuries (1) · Cognition Disorders (1) · Craniocerebral Trauma (1) · Heart Diseases (1)
Standard of Care (2) · Enoxaparin (1) · Esketamine (1) · Resuscitation Orders (1) · Sodium Chloride (1) · apixaban (1)
Cardinal Stefan Wyszynski University (1) · Copenhagen University Hospital, Rigshospitalet (1) · Guangzhou University of Traditional Chinese Medicine (1) · Qinhuangdao Hospital of Traditional Chinese Medicine (1) · Region Skane (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · University of Oulu (1)
China (3) · Australia (1) · Canada (1) · Denmark (1) · Finland (1) · Hong Kong (1) · Iceland (1) · Italy (1) · Malaysia (1) · Sweden (1) · United States (1)
Aimo Rissanen, MD, PhD (1) · Heikki Numminen, MD, PhD (1) · Liisa K Luostarinen, MD, PhD (1) · Matti E Hillbom, MD, PhD (1) · Min Lou, PhD, MD (1) · Qihui Zhang, MD. PhD (1) · Seppo S Juvela, MD, PhD (1) · Trine H Andreasen, MD (1) · Turgut Tatlisumak, MD, PhD (1)